U.S. Semiconductors Stock News

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...

Key Insights Given the large stake in the stock by institutions, First Internet Bancorp's stock price might be...

Fathom Holdings Inc. ( NASDAQ:FTHM ) insiders who acquired shares over the previous 12 months, can probably afford to...

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders might be concerned after seeing the share price drop 23% in the...

Aqua Pennsylvania, a subsidiary of Essential Utilities, recently completed a PFAS treatment system at its Edgely Water Treatment Facility in Bristol Township, Bucks County, marking its tenth operational PFAS facility since 2018 and funded by a US$5.70 million principal-forgiveness loan from PENNVEST at no direct cost to customers. This expanded PFAS treatment footprint under the new national drinking water standard highlights Essential Utilities’ growing role in addressing stricter water...

Earlier this month, Udemy announced a new AI-powered microlearning experience and a partnership with LG CNS that brings its AI learning platform to more than 500 Korean enterprises via LG CNS’s AX Platform. Together, these moves highlight how Udemy is using AI to reshape course delivery while tapping Korea’s innovation-focused corporate sector to deepen its enterprise footprint across Asia-Pacific. We’ll now look at how Udemy’s AI-driven microlearning rollout, especially its LG CNS...

Earlier in 2025, JLL’s Capital Markets group arranged US$306 million in senior non-recourse construction financing and US$78 million in preferred equity for the 678-unit Harborside 8 luxury waterfront multifamily project in Jersey City, with Kennedy-Wilson providing the floating-rate senior loan. This financing deepens Kennedy-Wilson’s partnership with the development team and underscores its focus on large-scale, higher-end rental housing projects in growth corridors. We’ll now examine how...

IRADIMED (IRMD) has quietly turned into a strong long term winner, with the stock up about 86% over the past year and roughly 3.5x over five years, outpacing many healthcare peers. See our latest analysis for IRADIMED. That momentum is not just a blip. IRADIMED’s 30 day share price return of about 15 percent and 90 day gain near 37 percent sit on top of an impressive multi year total shareholder return profile. If IRADIMED’s run has you rethinking your healthcare exposure, it might be worth...

Merus (MRUS) has quietly turned into one of the stronger biotech performers this year, with the stock up more than 120% year to date as investors reprice its antibody pipeline potential. See our latest analysis for Merus. That kind of rerating has not come out of nowhere, with Merus enjoying a powerful 90 day share price return of 42.16% and a standout three year total shareholder return of 597.77%. This suggests momentum is still firmly building around its pipeline story. If Merus has caught...

iRobot (IRBT) just hit two major turning points at once: a voluntary Chapter 11 filing and a Nasdaq delisting notice, effectively signaling the endgame for its public equity story. See our latest analysis for iRobot. Those Chapter 11 and delisting headlines basically crystallise what the share price had been hinting at for a while. A 1 year total shareholder return of around minus 91 percent and multi year losses show that momentum has not just faded; it has largely evaporated, as equity...

Duluth Holdings (DLTH) has just posted Q3 2026 results with revenue of $114.9 million and basic EPS of -$0.29, as investors continue to watch how its top line and per share losses evolve. The company has seen quarterly revenue move from $127.1 million in Q3 2025 to $114.9 million in Q3 2026, while basic EPS shifted from -$0.85 to -$0.29 over the same period. This sets the stage for a closer look at how stubborn losses are shaping margins and sentiment. See our full analysis for Duluth...

Wondering if LKQ is a quietly mispriced opportunity in the auto parts world, or a value trap hiding in plain sight? You are in the right place if you care about what you are actually paying for future cash flows. The stock has been choppy, with a 6.2% gain over the last week but still down 2.1% over 30 days, and notably 17.4% lower year to date and 15.5% over the past year, highlighting a long stretch of underperformance. Recent headlines have focused on LKQ's ongoing integration efforts...

Navan (NAVN) has just posted its Q3 2026 numbers, with revenue of about $194.9 million and a basic EPS loss of roughly $4.58 per share, while trailing 12 month revenue sits at around $656.3 million against a TTM EPS of about negative $7.99. The company has seen quarterly revenue move from roughly $126.9 million in Q2 2025 to $151.1 million in Q3 2025 and then to $194.9 million in Q3 2026, alongside basic EPS sliding from about negative $1.02 to negative $0.92 and then to negative $4.58 over...

Amdocs (DOX) just wrapped up FY 2025 with fourth quarter revenue of about $1.2 billion and EPS of $0.88, setting the stage against a trailing twelve month backdrop of $4.5 billion in revenue and EPS of $5.08. Over the past year, the company has seen revenue move from roughly $5.0 billion to $4.5 billion on a trailing basis, while trailing EPS has edged up from $4.27 to $5.08. This reflects a business that is leaning more on profitability than top line expansion, with margins now doing more of...

B. Riley Financial (RILY) has swung back to positive quarterly earnings in Q2 2025, posting revenue of about $199 million and EPS of roughly $2.23, even as trailing 12 month figures still reflect sizable losses. The company has seen revenue move from about $38 million in Q2 2024 to nearly $199 million in Q2 2025, while quarterly EPS has shifted from roughly negative $14.86 to positive $2.23. This sets up a sharp contrast between the latest quarter and its loss making recent history and puts...

ADT (ADT) shares have been drifting lately, and that sideways action is starting to look interesting when you line it up with the company’s improving fundamentals and still modest valuation profile. See our latest analysis for ADT. At around $8.14 per share, ADT’s solid year to date share price return contrasts with its softer three year total shareholder return. This suggests sentiment has improved recently as investors reassess its growth and risk profile. If ADT’s steady reset has your...

Yext (YEXT) has quietly outperformed many software peers this year, and that kind of steady climb usually means investors see something durable in the story, not just a passing sentiment shift. See our latest analysis for Yext. At a share price of $8.51, Yext’s steady year to date share price return of just over 30 percent and 1 year total shareholder return above 31 percent suggest momentum is still building as investors reassess its growth and profitability profile. If Yext’s climb has you...

UFP Technologies recently announced that long-serving CEO R. Jeffrey Bailly will retire at the June 4, 2026 annual meeting, with current President Mitchell Rock set to become CEO and join the board while Bailly transitions to Executive Chairman for a year. This carefully staged handover, led by an insider with more than three decades at the company, signals continuity in leadership and focus on the core MedTech business. We’ll now examine how this planned CEO transition to long-time insider...

F&G Annuities & Life (FG) has been quietly grinding higher, with the stock up around 5% over the past week and 7% over the past month, even as its year-to-date return stays negative. See our latest analysis for F&G Annuities & Life. That recent 7 day share price return of 5.33% looks more like a relief rally than a full trend change. The year to date share price return is still down 15.46%, and the 1 year total shareholder return sits at a weak negative 20.42%, despite a strong 3 year total...

Wondering if HNI is quietly turning into a value opportunity while most investors are looking elsewhere? Here is a look at what the market might be missing. HNI's share price has ticked up about 2.0% over the last week and 6.0% over the last month, even though it is still down 15.9% year to date and 20.8% over the last year. Zooming out, the stock is up 70.3% over 3 years and 41.6% over 5 years, which may point to a longer term recovery story beneath the recent weakness. Recent headlines...

Caleres, Inc. ( NYSE:CAL ) will pay a dividend of $0.07 on the 9th of January. Based on this payment, the dividend...

Key Insights Given the large stake in the stock by institutions, Digimarc's stock price might be vulnerable to their...

Dayforce (DAY) shares have quietly drifted over the past year, slipping about 10% even as revenue keeps growing near double digits and losses narrow, setting up an interesting risk reward discussion. See our latest analysis for Dayforce. Zooming out, the modest year to date share price decline contrasts with a still positive three year total shareholder return. This suggests sentiment has cooled recently even as the longer term story remains constructive. If Dayforce’s mixed momentum has you...

Recently, SNDL Inc. renewed its share repurchase program of up to C$100 million and saw sentiment strengthen after reports that the Trump administration may push to reclassify marijuana to Schedule III in the US, a move that could ease tax and financing constraints across the cannabis industry. Although SNDL remains primarily focused on Canada, shifting expectations around US federal cannabis policy are increasingly influencing how investors view its long-term optionality and capital...